RSSCommentary

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

Drug Development for Mental Illness: How Psychiatry Clinical Trial Sites are Meeting the Challenge of the COVID-19 Pandemic

| January 1, 2021

by Robert E. Litman, MD; Peter Sorantin, PhD; and Elia E. Acevedo-Diaz, MD Drs. Litman is with CBH Health, Georgetown University Medical School in Washington, DC. Dr. Sorantin is with Sorantin Outcomes, LLC, in Mountain Lakes, New Jersey. Dr. Acevedo-Diaz is with CBH Health and the National Institute of Mental Health (NIMH) in Bethesda, Maryland. […]

Continue Reading

Who Will Pay for Robotic Rehabilitation? The Growing Need for a Cost-effectiveness Analysis

Who Will Pay for Robotic Rehabilitation? The Growing Need for a Cost-effectiveness Analysis

| October 1, 2020

Continue Reading

Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?

Donkey Therapy and Hippotherapy: Two Faces of the Same Coin?

| January 1, 2020

Continue Reading

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

| July 1, 2018 | 0 Comments

Continue Reading

Neuroscience is the Next Oncology

Neuroscience is the Next Oncology

| April 1, 2018 | 0 Comments

by Michael D. Ehlers, MD, PhD Dr. Ehlers is with Biogen in Cambridge, Massachusetts. Innov Clin Neurosci. 2018;15(3–4):15–16 Funding: No funding was received for the preparation of this article. Disclosures: Dr. Ehlers is an employee and shareholder at Biogen Inc. in Cambridge, Massachusetts.

Continue Reading

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

When the Opioid Medications Go Missing: Confidentiality and Safety in Adolescents

| June 1, 2017 | 0 Comments

by Muhammad Hassan Majeed, MD Dr. Majeed is an Attending Psychiatrist at Natchaug Hospital, Norwich, Connecticut. Innov Clin Neurosci. 2017;14(5–6):25–27 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest relevant to the content of this article. Keywords: Opioids, diversion, safety, confidentiality, adolescents Abstract: Patients receiving […]

Continue Reading

It’s Time for Combination Therapies in Multiple Sclerosis

It’s Time for Combination Therapies in Multiple Sclerosis

| June 1, 2017 | 0 Comments

by Jagannadha Avasarala, MD, PhD Dr. Avasarala is Associate Professor of Neurology, Division of Neurology, Department of Medicine, University of South Carolina School of Medicine, Greenville Health System, Greenville, South Carolina. Innov Clin Neurosci. 2017;14(5–6):28–30 Funding: No funding was received for the preparation of this article. Financial Disclosures: The author has no conflicts of interest […]

Continue Reading